Proposed CREST-2 Trial Will Compare Drug Treatment With Revascularization In Carotid Artery Disease
Executive Summary
The trial could underscore the cost effectiveness of standalone drug therapy in treating some patients with carotid atherosclerosis, particularly with the blockbuster anticoagulant Plavix losing its patent protection this year and generics on the way.